Mckesson (MCK) Operating Margin (2009 - 2026)
Mckesson (MCK) reported Operating Margin of 2.23% for Q1 2026, up 48.0% year-over-year from 1.51% in Q1 2025, and up 46.4% quarter-over-quarter from 1.53% in Q4 2025.
Mckesson (MCK) Operating Margin (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Operating Margin data on file, last reported at 2.23% in Q1 2026.
- Operating Margin for Q1 2026 came in at 2.23%, up 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.54% (up 31.0% YoY), and the FY2026 annual result was 1.54%, up 31.0% from the prior year.
- Operating Margin improved to 2.23% in Q1 2026 per MCK's latest filing, from 1.53% in the prior quarter.
- Over five years, Operating Margin peaked at 2.23% in Q1 2026 and troughed at 0.62% in Q3 2024.
- A 5-year average of 1.38% and a median of 1.42% in 2023 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2023: Operating Margin surged 133 bps in 2022, then sank 97 bps in 2023.
- A 5-year view of Operating Margin shows it stood at 1.76% in 2022, then plunged by 55 bps to 0.79% in 2023, then soared by 62 bps to 1.28% in 2024, then climbed by 19 bps to 1.53% in 2025, then surged by 46 bps to 2.23% in 2026.
- Business Quant data shows MCK's Operating Margin at 2.23% in Q1 2026, 1.53% in Q4 2025, and 1.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.46% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.73% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.01% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -12.18% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23% |
| Dec 31, 2025 | 1.53% |
| Sep 30, 2025 | 1.36% |
| Jun 30, 2025 | 1.06% |
| Mar 31, 2025 | 1.75% |
| Dec 31, 2024 | 1.28% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | 1.30% |
| Mar 31, 2024 | 1.59% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 1.23% |
| Jun 30, 2023 | 1.48% |
| Mar 31, 2023 | 1.42% |
| Dec 31, 2022 | 1.76% |
| Sep 30, 2022 | 1.60% |
| Jun 30, 2022 | 1.54% |
| Mar 31, 2022 | 0.96% |
| Dec 31, 2021 | 0.43% |
| Sep 30, 2021 | 0.81% |
| Jun 30, 2021 | 0.91% |